News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Neuralert Technologies included in TIME’s List of the Best Inventions
The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.
Emily Whitehead’s CAR-T Cell Therapy Journey Featured on CBS
CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.
PCI Ventures Presents at Pennovation Works Showcase
The PCI Ventures at Pennovation Works Showcase took place in October 2022, in celebration of Pennovation Works' 6th Anniversary and PCI Ventures' 12 years of service to the Penn community.
PCI Ventures @ Pennovation Works Showcase Shines Spotlight on Penn-Affiliated Startups Making a Difference
PCI Ventures, a division of PCI specifically focused on creating early-stage businesses founded on Penn technology, recently held a showcase at Pennovation Works.
Drew Weismann Speaks on the Future of mRNA Technology in Bloomberg’s “The Big Take” Podcast
Weissman talks about his discovery and the impact of mRNA technology on the development of therapies for flu, cancer and rare genetic diseases.
Penn Dental Medicine Researchers Discover Potential Peripheral Nerve Injury Treatment
In their research, the team used SIS stem cells derived from gingival tissue to treat transected facial nerve and sciatic nerve crush injuries in rats.
PCI Team Member and Penn Medicine Featured in Washington Post
Carter Caldwell, Director of the Penn Medicine Co-Investment Program, was featured in the Washington Post’s Medical Mysteries column which described his journey following life-changing brain surgery.
Penn ranks #5 for undergraduate founders and #6 for graduate founders in Pitchbook Data’s ‘Top 100 colleges ranked by startup founders’
Penn ranked #5 for undergraduate founders and #6 for graduate founders. It also ranked #4 for female undergraduate founders and #5 for female graduate founders.
Penn Medicine and Candel Therapeutics partner to pursue potential solid tumor CAR-T cell therapy
The University of Pennsylvania’s Center for Cellular Immunotherapies, led by cell therapy pioneer Dr. Carl June, has entered into a cancer treatment collaboration with Candel Therapeutics.
Jon Epstein Serves as Keynote Speaker at Life Sciences Future – Biopharm, Discusses CAR-T and the Future of Healthcare
During the session, Epstein presented his research, which involves using in vivo CAR-T cell therapy to target cardiac fibrosis. He also discussed the future of healthcare.